Table 2.
Antimicrobials | Cut-Off Values |
MIC Breackpoint (µg/mL) | No. of Resistant /Total Investigated (%) C. jejuni Strains in the Study Years | Total (%) |
|||
---|---|---|---|---|---|---|---|
S | R | 2016 | 2018 | 2020 | |||
Erythromycin | 4 | 1 | 128 | 0/61 (0.0) | 0/23 (0.0) | 0/17 (0.0) | 0 (0.0) |
Ciprofloxacin | 0.5 | 0.125 | 16 | 42/61 (68.9) | 23/23 (100) | 15/17 (88.2) | 80 (79.2) |
Tetracycline | 1 | 0.5 | 64 | 24/61 (39.3) | 18/23 (78.3) | 10/17 (58.8) | 52 (49.5) |
Gentamicin | 2 | 0.125 | 16 | 0/61 (0.0) | 0/23 (0.0) | 0/17 (0.0) | 0 (0.0) |
Nalidixic acid | 16 | 1 | 64 | 40/61 (65.6) | 22/23 (95.7) | 17/17 (100) | 79 (78.2) |
Streptomycin | 4 | 0.25 | 16 | 4/61 (6.6) | 3/23 (13.0) | 1/17 (5.9) | 8 (7.9) |
Legend: S = susceptible; R = resistant.